ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
57,832.41
-0.70%
S&P 500
5,018.39
-0.34%
Dow Jones
37,903.29
0.23%
US Dollar vs Yen
155.188
-0.34%
Brent Oil
83.885
0.41%
Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. 10x Genomics Inc (TXG)

  7. 10x Genomics Inc (TXG) ニュース

TXG 10x Genomics Inc

26.92
0.00 (0.00%)
プレマーケット
最終更新日： 18:50:07
15分遅延
名称 銘柄コード 市場 種別
10x Genomics Inc TXG NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
Upgrade Icon
0.00 0.00% 26.92 18:50:07
始値 安値 高値 終値 前日終値
26.92
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/0105:05PRNUS10x Genomics Reports First Quarter 2024 Financial Results
2024/4/1105:05PRNUS10x Genomics to Report First Quarter 2024 Financial Results..
2024/3/2622:00PRNUS10x Genomics Commercially Launches Visium HD Spatial Gene..
2024/3/2205:05PRNUS10x Genomics Expands Xenium Menu with Multi-Modal Cell..
2024/3/1405:05PRNUS10x Genomics Begins Commercial Shipments of Chromium GEM-X..
2024/3/0706:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0508:40EDGAR2Form 144 - Report of proposed sale of securities
2024/2/2706:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2706:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2706:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2309:19EDGAR2Form 144 - Report of proposed sale of securities
2024/2/2309:06EDGAR2Form 144 - Report of proposed sale of securities
2024/2/2308:59EDGAR2Form 144 - Report of proposed sale of securities
2024/2/2106:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2106:05PRNUS10x Genomics to Present at the 44th Annual TD Cowen Health..
2024/2/1607:33EDGAR2Form S-8 - Securities to be offered to employees in employee..
2024/2/1607:16EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/2/1606:05EDGAR2Form 8-K - Current report
2024/2/1606:05PRNUS10x Genomics Reports Fourth Quarter and Full Year 2023..
2024/2/1406:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0806:05PRNUS10x Genomics Expands Leadership in Single Cell Analysis with..
2024/2/0606:05PRNUS10x Genomics to Showcase New Cutting-Edge Technologies and..
2024/1/2506:05PRNUS10x Genomics to Report Fourth Quarter and Full Year 2023..
2024/1/1906:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1708:08EDGAR2Form 144 - Report of proposed sale of securities
2024/1/1706:07EDGAR2Form 8-K - Current report
2024/1/0823:00EDGAR2Form 8-K - Current report
2024/1/0823:00PRNUS10x Genomics Announces Preliminary Fourth Quarter and Full..
2023/12/3006:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/3006:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/2206:05PRNUS10x Genomics to Present at the 42nd Annual J.P. Morgan..
2023/12/2106:05PRNUS10x Genomics Launches Xenium Catalyst Network
2023/12/1923:00PRNUSIntegrative Study Conducted by 10x Genomics Combines Single..
2023/12/1907:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1507:09EDGAR2Form 144 - Report of proposed sale of securities
2023/12/1406:26PRNUSHigh Sensitivity and Specificity of the Xenium Platform from..
2023/12/0723:00PRNUS10x Genomics and NIH CARD to Create Comprehensive Single..
2023/11/2808:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/2808:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/2808:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/2808:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/2306:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/2306:25EDGAR2Form 144 - Report of proposed sale of securities
2023/11/2306:25EDGAR2Form 144 - Report of proposed sale of securities
2023/11/2306:08EDGAR2Form 144 - Report of proposed sale of securities
2023/11/2108:08EDGAR2Form 144 - Report of proposed sale of securities
2023/11/1807:22PRNUS10x Genomics Wins Another Patent Infringement Case Against..
2023/11/1706:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/0706:05PRNUSOWKIN Integrates 10x Genomics Spatial Omics and Single-Cell..
2023/11/0305:05EDGAR2Form 8-K - Current report

最近閲覧した銘柄

NASDAQ
TXG
10x Genomics
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有